Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
131.63
-1.51 (-1.13%)
Mar 31, 2025, 9:53 AM EDT - Market open
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 164, with a low estimate of 122 and a high estimate of 217. The average target predicts an increase of 24.59% from the current stock price of 131.63.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tenet Healthcare stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 6 | 5 | 5 | 5 | 5 |
| Buy | 9 | 8 | 9 | 10 | 10 | 11 |
| Hold | 1 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 16 | 17 | 18 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Initiates $165 | Buy | Initiates | $165 | +25.35% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $177 | Buy | Reiterates | $177 | +34.47% | Feb 13, 2025 |
| Barclays | Barclays | Buy Maintains $190 → $161 | Buy | Maintains | $190 → $161 | +22.31% | Feb 13, 2025 |
| Keybanc | Keybanc | Buy Maintains $200 → $185 | Buy | Maintains | $200 → $185 | +40.55% | Jan 7, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $190 → $175 | Strong Buy | Maintains | $190 → $175 | +32.95% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
21.13B
from 20.67B
Increased by 2.25%
Revenue Next Year
22.21B
from 21.13B
Increased by 5.12%
EPS This Year
12.30
from 32.70
Decreased by -62.39%
EPS Next Year
13.34
from 12.30
Increased by 8.48%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.0B | 24.0B | 25.0B | ||
| Avg | 21.1B | 22.2B | 23.4B | ||
| Low | 20.4B | 21.2B | 22.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.2% | 13.4% | 12.6% | ||
| Avg | 2.3% | 5.1% | 5.5% | ||
| Low | -1.5% | 0.5% | -0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.57 | 15.19 | 17.76 | ||
| Avg | 12.30 | 13.34 | 15.18 | ||
| Low | 11.34 | 11.23 | 12.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -58.5% | 23.5% | 33.1% | ||
| Avg | -62.4% | 8.5% | 13.8% | ||
| Low | -65.3% | -8.7% | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.